SeaCrest Wealth Management’s Armata Pharmaceuticals ARMP Stock Holding History

SeaCrest Wealth Management’s Portfolio ARMP Stock Details ARMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$269K	Hold	41,524	–	–	0.03%	446
2026 Q1	$425K	Buy	41,524 +536	+1%	+$4.51K	0.05%	369
2025 Q4	$274K	Buy	40,988 +6,034	+17%	+$33.1K	0.03%	489
2025 Q3	$113K	Hold	34,954	–	–	0.01%	615
2025 Q2	$66.4K	Hold	34,954	–	–	0.01%	611
2025 Q1	$51K	Hold	34,954	–	–	0.01%	650
2024 Q4	$64.7K	Hold	34,954	–	–	0.01%	645
2024 Q3	$82.8K	Hold	34,954	–	–	0.01%	639
2024 Q2	$96.1K	Buy	34,954 +2,177	+7%	+$6.21K	0.01%	599
2024 Q1	$137K	Buy	32,777 +14,647	+81%	+$53K	0.02%	583
2023 Q4	$56.4K	Hold	18,130	–	–	0.01%	611
2023 Q3	$54.4K	Hold	18,130	–	–	0.01%	610
2023 Q2	$20.7K	Hold	18,130	–	–	﹤0.01%	624
2023 Q1	$30.3K	Hold	18,130	–	–	﹤0.01%	624
2022 Q4	$22.5K	Buy	18,130 +580	+3%	+$1.51K	﹤0.01%	629
2022 Q3	$74K	Hold	17,550	–	–	0.01%	605
2022 Q2	$68K	Buy	17,550 +850	+5%	+$3.69K	0.01%	998
2022 Q1	$82K	Buy	16,700 +3,200	+24%	+$16.4K	0.01%	697
2021 Q4	$74K	Hold	13,500	–	–	0.01%	695
2021 Q3	$49K	Hold	13,500	–	–	0.01%	671
2021 Q2	$54K	Hold	13,500	–	–	0.01%	685
2021 Q1	$65K	Buy	13,500 +845	+7%	+$4.15K	0.01%	652
2020 Q4	$38K	Hold	12,655	–	–	0.01%	618
2020 Q3	$40K	Hold	12,655	–	–	0.01%	575
2020 Q2	$50K	Hold	12,655	–	–	0.01%	545
2020 Q1	$39K	Buy	+12,655	New	+$43.6K	0.01%	501

Other funds holding ARMP

MAM

Madison Asset Management Madison, Wisconsin $8.39B AUM 16.36% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

DIG

Dauntless Investment Group Etna, New Hampshire $127M AUM 42.43% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Edgewood Management Greenwich, Connecticut $9.69B AUM 6.52% 1-Year Est. Return

SeaCrest Wealth Management's ARMP Position: Q2 2026 in Review

SeaCrest Wealth Management held its Armata Pharmaceuticals (ARMP) position steady in Q2 2026 at 41,524 shares worth $269K. The position accounts for 0.03% of the portfolio, ranked #446.

SeaCrest Wealth Management first reported a position in ARMP in Q1 2020 and has held it in 26 quarters since. The position peaked at $425K in Q1 2026. 53 funds tracked by Wall St. Rank hold ARMP as of Q2 2026.

SeaCrest Wealth Management held 41,524 shares of Armata Pharmaceuticals worth $269K as of Q2 2026.
SeaCrest Wealth Management left its Armata Pharmaceuticals share count unchanged in Q2 2026.
Armata Pharmaceuticals made up 0.03% of SeaCrest Wealth Management's portfolio in Q2 2026, its #446 holding.
SeaCrest Wealth Management first reported a position in Armata Pharmaceuticals in Q1 2020 and has held it in 26 quarters since.
SeaCrest Wealth Management's Armata Pharmaceuticals position peaked at $425K in Q1 2026.
53 funds tracked by Wall St. Rank held Armata Pharmaceuticals as of Q2 2026.

Based on SeaCrest Wealth Management's 13F filing for Q2 2026, filed 9 Jul 2026.